Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05040529
Other study ID # 3-2021-0039
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date March 1, 2009
Est. completion date March 28, 2022

Study information

Verified date September 2021
Source Gangnam Severance Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Perioperative clincal outcome between PLDRH and conventional open donor right hepatectomy (ODRH) will be compared retrospectively.


Description:

the superiority of laparoscopic liver resection was well known in terms of reduced blood loss and minimized hospital stay compared with open liver resection. However, pure laparoscopic donor hepatectomy is a challenging procedure for beginner liver surgeons because of the major vessel preservation required during liver parenchymal transection. this study was designed to identify the superiority of laparoscopic donor hepatectomy.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date March 28, 2022
Est. primary completion date February 28, 2021
Accepts healthy volunteers
Gender All
Age group 17 Years to 65 Years
Eligibility Inclusion Criteria: - patients received right or right extended hepatectomy for liver donation at gangnam severance hospital Exclusion Criteria: - none

Study Design


Related Conditions & MeSH terms

  • Healthy Donors for Liver Transplantation

Intervention

Procedure:
pure laparoscopic donor hepatectomy
pure laparoscopic donor hepatectomy: patients who underwent pure laparoscopic right or right extended hepatectomy for liver donation at gangnam severance hospital
conventional open donor hepatectomy
conventional open donor hepatectomy: patients who underwent conventional right or right extended hepatectomy for liver donation at gangnam severance hospital

Locations

Country Name City State
Korea, Republic of Gangnam Severacne Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Gangnam Severance Hospital

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (1)

Hong SK, Lee KW, Choi Y, Kim HS, Ahn SW, Yoon KC, Kim H, Yi NJ, Suh KS. Initial experience with purely laparoscopic living-donor right hepatectomy. Br J Surg. 2018 May;105(6):751-759. doi: 10.1002/bjs.10777. Epub 2018 Mar 26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary blood loss during hepatectomy bleeding amount during hepatectomy will be calculated in mL. based on the blood in the sucker machine and the surgical towels. intraoperative
See also
  Status Clinical Trial Phase
Completed NCT02413983 - Comparison of Postoperative Outcome of Hepatectomy for Living Donors According to Three Different Incision